Quantcast

Latest Vaccination Stories

2014-05-19 23:07:53

Dr. William Hearl will discuss the missing link in enhancing the effectiveness of DNA vaccines in a panel discussion on Wednesday, May 21 hosted by Ed Butler of the BBC Hershey, PA & Rockville, MD (PRWEB) May 19, 2014 Immunomic Therapeutics, Inc. (ITI), a vaccine pioneer in the biotechnology industry, is proud to announce that the company’s CEO, Dr. William G. Hearl, will be a featured panelist at the prestigious Future in Review (FiRe) Conference hosted by Strategic News Service...

2014-05-16 12:27:03

Anti-Mers-CoV Synthetic Replikins Vaccine(TM) Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ -- A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Replikin structures that are not just homologous but are identical in the virus genes infecting both camels and humans, and conserved since 2012 in cases from all countries affected. Replikins, Ltd. has...

2014-05-15 12:36:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global H1N1 Vaccines Industryhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/global_h1n1_vaccines_industry.html This report analyzes the Global market for H1N1 Vaccines in US$ Million. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The...

2014-05-15 12:33:41

Public health initiative aims to increase unacceptably low adult vaccination rates PHILADELPHIA, May 15, 2014 /PRNewswire-USNewswire/ -- The American College of Physicians (ACP), CECity, and Pfizer Inc. (NYSE:PFE) have announced a new initiative designed to increase adult immunization rates by assisting physicians and other health care providers in strongly recommending appropriate vaccination and tracking adult immunization rates for quality measurement and improvement. The three...

A Megadose Of The Measles Virus Kills Woman's Cancer In Early Trial
2014-05-15 11:15:31

Brett Smith for redOrbit.com - Your Universe Online In an early stage, proof-of-principle trial, researchers from the Mayo Clinic have demonstrated that a modified version of the measles virus is capable of destroying cancerous cells while leaving normal healthy tissue intact, according to a new report in Mayo Clinic Proceedings. In the trial, two patients with multiple myeloma were injected with a single massive dose of a genetically-engineered measles virus – enough to inoculate 10...

2014-05-14 08:29:41

DaVita recognized for groundbreaking teammate immunization program DENVER, May 14, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, was recognized at the National Adult and Influenza Immunization Summit (NAIIS) as the national winner in the "Healthcare Personnel Campaign" category of the 2014 Immunization Excellence Awards....

2014-05-13 04:22:33

BLUE BELL, Pa., May 13, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today it acquired worldwide rights (excluding China) for early preclinical therapies addressing Alzheimer's disease and multiple sclerosis based on the academic research of Dr. Bin Wang, a professor at Fudan University's Shanghai Medical College. Dr. Wang is a pioneer in the field of DNA therapies, having worked closely with Dr. David Weiner at the University of Pennsylvania. Dr. Wang was the...

2014-05-12 16:29:32

PALO ALTO, Calif., May 12, 2014 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, have entered into a definitive merger agreement. Upon closing of the transaction, MabVax and Telik will be combined into a publicly traded company focused on the development of proprietary immunotherapy-based products to diagnose and treat cancer. Under the terms of the merger...

2014-05-12 16:29:28

SAN DIEGO, May 12, 2014 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (Nasdaq: TELK), aclinical stage oncology drug development company have entered into a definitive merger agreement. Upon closing of the transaction, MabVax and Telik will be combined into a publicly traded company focused on the development of proprietary immunotherapy-based products to diagnose and treat cancer. Under the terms of the merger agreement,...

2014-05-12 08:32:05

Olympic Medalist swimmer and mother, Dara Torres, and the National Association of School Nurses launch multi-city health initiative as part of Voices of Meningitis(TM) SILVER SPRING, Md. and SWIFTWATER, Pa., May 12, 2014 /PRNewswire/ -- Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,(1) a national survey revealed that more than two in three mothers have little to no knowledge of the Centers for Disease Control and Prevention's...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related